Highlights Hualan Biological Engineering Inc.

Equities

002007

CNE000001JN8

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 10/05/2024 am IST			5-day change	1st Jan Change
19.99 ^CNY	+1.06%		+2.67%	-9.67%

25/04	Hualan Biological Engineering Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
02/04	Hualan Biological Engineering's Profit Rises 38%; Tops EPS, Revenue Estimates	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hualan Biological Engineering Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04	CI
Hualan Biological Engineering's Profit Rises 38%; Tops EPS, Revenue Estimates	02/04	MT
Hualan Biological Engineering Inc. Proposes Profit Distribution for 2023	02/04	CI
Hualan Biological Engineering Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	30/03	CI
Hualan Biological Engineering Obtains Blood Collection License	02/02	MT
Hualan Biological Engineering Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	29/23/29	CI
Hualan Biological Engineering Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	23/23/23	CI
Hualan Biological Engineering's Plasma Station Gets Permit to Collect Blood	16/23/16	MT
Hualan Biological Engineering's Unit Gets Nod to Trial Antibody Injection	07/23/07	MT
Hualan Biological Engineering Inc. Announces Final Dividend on Share A for 2022, Payable on June 14, 2023	08/23/08	CI
Hualan Biological Engineering Obtains Blood Plasma Collection License	31/23/31	MT
Hualan Biological Engineering's Unit Gets Nod for Trial of Tumor Drug	05/23/05	MT
Hualan Biological Engineering Inc. Approves Cash Dividend for 2022	25/23/25	CI
Hualan Biological Engineering Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	21/23/21	CI
Hualan Biological Engineering Inc. Proposes Final Dividend for 2022	31/23/31	CI
Hualan Biological Bacterin Registers Freeze-Dried Human Rabies Vaccine	01/23/01	MT
Hualan Biological Engineering Wins Approval to Build Apheresis Stations	28/22/28	MT
Hualan Biological Engineering Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022	30/22/30	CI
Hualan Biological Engineering Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	22/22/22	CI
Hualan Biological Engineering Inc. Announces Final Cash Dividend on A Shares for 2021, Payable on 16 June 2022	09/22/09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Hualan Biological Engineering Inc.

Equities

002007

CNE000001JN8

Highlights

Filters